Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
1.355
+0.025 (1.88%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Galectin Therapeutics Employees
Galectin Therapeutics had 15 employees as of December 31, 2024. The number of employees increased by 1 or 7.14% compared to the previous year.
Employees
15
Change (1Y)
1
Growth (1Y)
7.14%
Revenue / Employee
n/a
Profits / Employee
-$3,146,667
Market Cap
84.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
GALT News
- 24 days ago - Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Galectin Therapeutics to Present at the 2025 MASH-TAG Conference - GlobeNewsWire
- 4 months ago - Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday? - Benzinga
- 4 months ago - Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH - GlobeNewsWire
- 5 months ago - Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting - GlobeNewsWire
- 5 months ago - Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update - GlobeNewsWire
- 6 months ago - Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting - GlobeNewsWire
- 8 months ago - Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire